Metabolomic Alterations in the Vascular Compartment in Patients With Sepsis - Trial NCT03655899

Name: Clinical Trial NCT03655899
Creator: Pär Johansson
Keywords: Endothelial Dysfunction, clinical trial, Denmark

Access comprehensive clinical trial information for NCT03655899 through Pure Global AI's free database. This phase not specified trial is sponsored by Pär Johansson and is currently Terminated. The study focuses on Endothelial Dysfunction. Target enrollment is 37 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

NCT03655899

Terminated

Trial Details

ClinicalTrials.gov • NCT03655899

View on ClinicalTrials.gov

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Metabolomic Alterations in the Vascular Compartment in Patients With Sepsis

Metabolomic Alterations in the Vascular Compartment in Patients With Sepsis - an Observational Study

Study Focus

Disease/Condition

Endothelial Dysfunction

Study Type

Observational

Sponsor & Location

Primary Sponsor

Pär Johansson

Funder

Rigshospitalet, Denmark

Location

Copenhagen, Denmark

Timeline & Enrollment

Phase

N/A

Start Date

Oct 23, 2017

End Date

Mar 12, 2019

Enrollment

37 participants

Primary Outcome

Shock induced endotheliopaty

Summary

This study will investigate the metabolic alterations of vascular cells caused by sepsis and septic shock

ICD-10 Classifications

Other peripheral vascular diseases

Atherosclerosis of arteries of extremities

Other specified peripheral vascular diseases

Renovascular hypertension

Other disorders of arteries and arterioles

Data Source

Registry

ClinicalTrials.gov

Trial ID

NCT03655899

Type

Non-Device Trial